London L, McKearn J P
E. I. du Pont de Nemours & Co., Glenolden, Pennsylvania 19036.
J Exp Med. 1987 Nov 1;166(5):1419-35. doi: 10.1084/jem.166.5.1419.
Hematopoietic cell development is regulated by a series of growth factors that are progressively restricted in their biological activity. IL-3 is a multi-lineage growth factor that supports the growth and differentiation of progenitor cells belonging to multiple lineages. However, the mechanism by which IL-3 induces proliferation and differentiation of these cells is not completely understood. In this report, we have used two IL-3-dependent cell lines, FDC-P1 (a myeloid progenitor) and F15.12 (a lymphoid progenitor) to investigate IL-3-mediated growth and differentiation. When either FDC-P1 or FL5.12 cells are deprived of IL-3, greater than 90% of all cells accumulate in the G0 phase of the cell cycle. Upon readdition of IL-3, the cells will reenter the active phases of the cell cycle. Therefore, IL-3 can act as both a competence (G0----G1) factor, and a progression (G1----M) factor for hematopoietic precursor clones. FDC-P1 cells can also proliferate in response to granulocyte/macrophage colony-stimulating factor (G/M-CSF) and IL-4 (B cell stimulatory factor 1 [BSF-1]). However, resting (G0) FDC-P1 cells have lost their ability to grow in response to both G/M-CSF and IL-4, even though both factors can induce a G0----G1 transition. Therefore, G/M-CSF or IL-4 behave as progression factors among certain IL-3-responsive clones, and in those cases only in defined points in the cell cycle. Both IL-4 and G/M-CSF can maintain long-term growth of FDC-P1 cells. Upon removal of factor for 24 h, these clones accumulate in the G1 phase of the cell cycle and do not appear to enter G0 even after 36 h of factor deprivation. Therefore, cells maintained in G/M-CSF or IL-4 have altered growth requirements compared with the IL-3-dependent lines from which they were derived. The ability of various hematopoietic growth factors to regulate cell cycle progression in IL-3-dependent cell lines is dependent not only upon the lineage from which these cells were derived, but also the phase of the cell cycle in which those cells reside. The consequences of these interactions dictate the manner by which various clones will respond to CSFs and whether the cells will grow and/or differentiate.
造血细胞的发育受一系列生物活性逐渐受限的生长因子调控。白细胞介素-3(IL-3)是一种多谱系生长因子,可支持多个谱系祖细胞的生长和分化。然而,IL-3诱导这些细胞增殖和分化的机制尚未完全明确。在本报告中,我们使用了两种依赖IL-3的细胞系,FDC-P1(一种髓系祖细胞)和F15.12(一种淋巴系祖细胞)来研究IL-3介导的生长和分化。当FDC-P1或FL5.12细胞缺乏IL-3时,超过90%的细胞会积聚在细胞周期的G0期。重新添加IL-3后,细胞将重新进入细胞周期的活跃阶段。因此,IL-3既可以作为造血前体克隆的起始(G0→G1)因子,也可以作为进展(G1→M)因子。FDC-P1细胞也可以对粒细胞/巨噬细胞集落刺激因子(G/M-CSF)和IL-4(B细胞刺激因子1 [BSF-1])产生增殖反应。然而,静止(G0)的FDC-P1细胞已经失去了对G/M-CSF和IL-4产生生长反应的能力,尽管这两种因子都可以诱导G0→G1转变。因此,G/M-CSF或IL-4在某些对IL-3有反应的克隆中仅在细胞周期的特定点作为进展因子起作用。IL-4和G/M-CSF都可以维持FDC-P1细胞的长期生长。去除因子24小时后,这些克隆积聚在细胞周期的G1期,即使在去除因子36小时后似乎也不会进入G0期。因此,与它们所源自的依赖IL-3的细胞系相比,维持在G/M-CSF或IL-4中的细胞具有改变的生长需求。各种造血生长因子调节依赖IL-3的细胞系中细胞周期进展的能力不仅取决于这些细胞所源自的谱系,还取决于这些细胞所处的细胞周期阶段。这些相互作用的结果决定了各种克隆对集落刺激因子(CSF)的反应方式以及细胞是否会生长和/或分化。